Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DB23FYQ29
Awardee
Awarding agency
Obligated
$61,896

Award facts

Contract value 100% obligated
$61,896.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $61,896 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between June 26 and July 18, 2023. Xolair is used to treat allergic asthma and chronic idiopathic urticaria. No set aside designation or subcontractors were identified. The award was made using an unspecified agency-wide contract vehicle to fulfill the DLA's mission to provide logistics support to the military services.

Quick answers

Who was awarded contract SPE2DB23FYQ29?

SPE2DB23FYQ29 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 26, 2023.

How much is contract SPE2DB23FYQ29 worth?

The government has obligated $61,896 on SPE2DB23FYQ29.

Is contract SPE2DB23FYQ29 an order under another contract?

Yes. SPE2DB23FYQ29 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.

Was contract SPE2DB23FYQ29 competed?

The extent of competition for SPE2DB23FYQ29 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award